The Impact of the COVID-19 Pandemic on Patients with Ulcerative Colitis: Results from a Global Ulcerative Colitis Narrative Patient Survey-Reference-Cited by-同舟云学术

The Impact of the COVID-19 Pandemic on Patients with Ulcerative Colitis: Results from a Global Ulcerative Colitis Narrative Patient Survey

Published:2023-12-04 Issue:2 Volume:41 Page:598-617
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Peyrin-Biroulet Laurent,Ylänne Karoliina^ORCID,Sipes Allyson,Segovia Michelle^ORCID,Gardiner Sean^ORCID,Cappelleri Joseph C.^ORCID,Mulvey Amy,Panaccione Remo

Funder

Pfizer

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12325-023-02673-0.pdf

Reference26 articles.

1. Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. Lancet. 2017;389:1756–70.

2. Jones JL, Nguyen GC, Benchimol EI, et al. The impact of inflammatory bowel disease in Canada 2018: quality of life. J Can Assoc Gastroenterol. 2019;2:S42–8.

3. Goodsall TM, Han S, Bryant RV. Understanding attitudes, concerns, and health behaviors of patients with inflammatory bowel disease during the coronavirus disease 2019 pandemic. J Gastroenterol Hepatol. 2021;36:1550–5.

4. Graff LA, Fowler S, Jones JL, et al. Crohn’s and colitis Canada’s 2021 impact of COVID-19 and inflammatory bowel disease in Canada: mental health and quality of life. J Can Assoc Gastroenterol. 2021;4:S46–53.

5. Jones JL, Benchimol EI, Bernstein CN, et al. Crohn’s and colitis Canada’s 2021 impact of COVID-19 and inflammatory bowel disease in Canada: health care delivery during the pandemic and the future model of inflammatory bowel disease care. J Can Assoc Gastroenterol. 2021;4:S61–7.